GeneTex Augments Its GPCR Reagent Portfolio With a Highly Specific CXCR2 Recombinant Monoclonal Antibody
GeneTex, a multinational antibody manufacturer, announces a new addition to its growing product line of validated recombinant monoclonal antibodies against G protein-coupled receptors (GPCRs). CXC...
GeneTex Addresses GPCR Targets With Its Recombinant Monoclonal Antibody Production Platform
GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform and augmented validation protocols to generate immunological reagents against high-value targets...